Literature DB >> 27936936

Additional Evidence Supports Association of Common Variants in COL11A1 with Increased Risk of Hip Osteoarthritis Susceptibility.

Jinhua Wang1, Chen Zhang2, Stephen G Wu3, Chi Shang4, Lun Huang1, Tong Zhang1, Wen Zhang1, Yanping Zhang1, Lei Zhang1.   

Abstract

OBJECTIVE: In a recent study single nucleotide polymorphisms (SNPs) in the COL11A1 gene were found to be associated with hip osteoarthritis (OA) among European populations. In this study, our aim was to identify common genetic variants in COL11A1 predisposing to primary hip OA in Han Chinese individuals.
METHODS: We designed a case-control study that included 313 hip OA patients and 911 unrelated healthy controls. Fourteen tagging single-nucleotide polymorphisms (SNPs) were genotyped, and single SNP and haplotypic association analyses were performed.
RESULTS: Two SNPs (rs1241164 and rs4907986) were found to be significantly associated with hip OA risk (adjusted p = 0.000731 and 0.000477). An increased risk of OA was associated with possession of the C allele of rs1241164 (adjusted odds ratio [OR] = 1.73, 95% confidence interval [CI] = 1.27-2.36) and the T allele of rs4907986 (adjusted OR = 1.72, 95% CI = 1.24-2.35). Similar results were confirmed via genotypic association analyses. Moreover, two different haplotype blocks, including rs1241164 and rs4907986, respectively, were found to be strongly associated with hip OA risk as well.
CONCLUSION: Variants in the COL11A1 gene modify individual susceptibility to hip OA in the Han Chinese population.

Entities:  

Keywords:  genetics; osteoarthritis; single-nucleotide polymorphisms

Mesh:

Substances:

Year:  2016        PMID: 27936936     DOI: 10.1089/gtmb.2016.0308

Source DB:  PubMed          Journal:  Genet Test Mol Biomarkers        ISSN: 1945-0257


  1 in total

1.  Gene-gene interactions of the Wnt/β-catenin signaling pathway in knee osteoarthritis.

Authors:  Javier Fernández-Torres; Yessica Zamudio-Cuevas; Alberto López-Reyes; Daniela Garrido-Rodríguez; Karina Martínez-Flores; Carlos Alberto Lozada; José Francisco Muñóz-Valle; Edith Oregon-Romero; Gabriela Angélica Martínez-Nava
Journal:  Mol Biol Rep       Date:  2018-08-06       Impact factor: 2.316

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.